Literature DB >> 1376558

Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid.

S A Frautschy1, G M Cole, A Baird.   

Abstract

The presence of extracellular deposits of beta-amyloid protein in the brain is a hallmark of Alzheimer's disease (AD). In an effort to determine the effect of amyloid in an animal model, the authors injected amyloid cores isolated from AD brains into the cortex and hippocampus of rats. Lipofuscin, a major contaminant of the plaque core preparation, was injected on the contralateral side and used as a control to induce an analogous phagocytic cell response. Rats were sacrificed 2 days, 7 days, and 1 month after injection and amyloid located by four histochemical techniques. Amyloid and lipofuscin move from the site of injection into otherwise undamaged neuropil, persist for at least 1 month and are both associated with increases in glial fibrillary acidic protein and microglia (OX-42) staining. By 1 week, many of the amyloid cores are ingested by phagocytes. Some of the beta-amyloid-containing phagocytes migrate to the vessels and to the ventricles, and by 1 month, a significant amount of the amyloid is directly associated with the vessels. This suggests that phagocytic cells can internalize exogenous amyloid and attempt to clear it from the central nervous system (CNS). Therefore, the observed distribution of amyloid is not necessarily the initial site of deposition.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376558      PMCID: PMC1886549     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

1.  Phagocytosis of beta/A4 amyloid fibrils of the neuritic neocortical plaques.

Authors:  H M Wisniewski; M Barcikowska; E Kida
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Anti-inflammatory drugs and Alzheimer disease.

Authors:  P L McGeer; E McGeer; J Rogers; J Sibley
Journal:  Lancet       Date:  1990-04-28       Impact factor: 79.321

3.  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

Authors:  E Levy; M D Carman; I J Fernandez-Madrid; M D Power; I Lieberburg; S G van Duinen; G T Bots; W Luyendijk; B Frangione
Journal:  Science       Date:  1990-06-01       Impact factor: 47.728

4.  Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension.

Authors:  P Walicke; W M Cowan; N Ueno; A Baird; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

5.  Differences between vascular and plaque core amyloid in Alzheimer's disease.

Authors:  F Prelli; E Castaño; G G Glenner; B Frangione
Journal:  J Neurochem       Date:  1988-08       Impact factor: 5.372

6.  Degradation and regurgitation of extracellular proteins by cultured mouse peritoneal macrophages and baby hamster kidney fibroblasts. Kinetic evidence that the transfer of proteins to lysosomes is not irreversible.

Authors:  S Buktenica; S J Olenick; R Salgia; A Frankfater
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

7.  Modified Bielschowsky stain and immunohistochemical studies on striatal plaques in Alzheimer's disease.

Authors:  T Suenaga; A Hirano; J F Llena; S H Yen; D W Dickson
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

8.  Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease.

Authors:  J Rogers; J Luber-Narod; S D Styren; W H Civin
Journal:  Neurobiol Aging       Date:  1988 Jul-Aug       Impact factor: 4.673

9.  Effects of injected Alzheimer beta-amyloid cores in rat brain.

Authors:  S A Frautschy; A Baird; G M Cole
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

10.  Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease.

Authors:  S Bahmanyar; G A Higgins; D Goldgaber; D A Lewis; J H Morrison; M C Wilson; S K Shankar; D C Gajdusek
Journal:  Science       Date:  1987-07-03       Impact factor: 47.728

View more
  45 in total

1.  Microglia in Alzheimer's disease and transgenic models. How close the fit?

Authors:  D W Dickson
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  The impact of glial activation in the aging brain.

Authors:  Aileen M Lynch; Kevin J Murphy; Brian F Deighan; Julie-Ann O'Reilly; Yuri K Gun'ko; Thelma R Cowley; Rodrigo E Gonzalez-Reyes; Marina A Lynch
Journal:  Aging Dis       Date:  2010-09-04       Impact factor: 6.745

3.  Subcutaneous Nogo receptor removes brain amyloid-beta and improves spatial memory in Alzheimer's transgenic mice.

Authors:  James H Park; Gabriel A Widi; David A Gimbel; Noam Y Harel; Daniel H S Lee; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2006-12-20       Impact factor: 6.167

Review 4.  Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.

Authors:  Elisabetta Vegeto; Valeria Benedusi; Adriana Maggi
Journal:  Front Neuroendocrinol       Date:  2008-04-29       Impact factor: 8.606

5.  Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease.

Authors:  R O Weller; A Massey; T A Newman; M Hutchings; Y M Kuo; A E Roher
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

6.  Effects of transforming growth factor-beta (isoforms 1-3) on amyloid-beta deposition, inflammation, and cell targeting in organotypic hippocampal slice cultures.

Authors:  M E Harris-White; T Chu; Z Balverde; J J Sigel; K C Flanders; S A Frautschy
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

7.  Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.

Authors:  Yosef Koronyo; Brenda C Salumbides; Julia Sheyn; Lindsey Pelissier; Songlin Li; Vladimir Ljubimov; Michelle Moyseyev; David Daley; Dieu-Trang Fuchs; Michael Pham; Keith L Black; Altan Rentsendorj; Maya Koronyo-Hamaoui
Journal:  Brain       Date:  2015-06-06       Impact factor: 13.501

8.  Curcumin restores innate immune Alzheimer's disease risk gene expression to ameliorate Alzheimer pathogenesis.

Authors:  B Teter; T Morihara; G P Lim; T Chu; M R Jones; X Zuo; R M Paul; S A Frautschy; G M Cole
Journal:  Neurobiol Dis       Date:  2019-04-02       Impact factor: 5.996

Review 9.  Why pleiotropic interventions are needed for Alzheimer's disease.

Authors:  Sally A Frautschy; Greg M Cole
Journal:  Mol Neurobiol       Date:  2010-05-02       Impact factor: 5.590

Review 10.  Chaperone signalling complexes in Alzheimer's disease.

Authors:  John Koren; Umesh K Jinwal; Daniel C Lee; Jeffrey R Jones; Cody L Shults; Amelia G Johnson; Laura J Anderson; Chad A Dickey
Journal:  J Cell Mol Med       Date:  2009-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.